Seniors

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

Following a Type A meeting, the FDA's Center for Biologics Evaluation and Research has notified Moderna that its biologics license...

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna has requested a Type...

Hackensack Meridian Health and Lumeris Expand Value-Based Partnership to Include Traditional Medicare Through MSSP ACO

Collaboration builds on high-performing Clinically Integrated Network for Commercial and Medicare Advantage to improve outcomes and care coordination for New...

error: Content is protected !!